Climate change predictions indicate that global temperatures Introduction: are likely to exceed those seen in the last 200,000 years, rising by around 4°C above pre-industrial levels by 2100 (without effective mitigation of current emission rates). In regions of the world set to experience extreme temperatures, women often work outside in agriculture even during pregnancy. The implications of heat strain in pregnancy on maternal health and pregnancy outcome are not well understood. This protocol describes a study to assess the physiological response of pregnant women to environmental heat stress and the immediate effect this has on fetal wellbeing.
Introduction
The world is getting hotter and current projections show no sign of this warming slowing down 1, 2 . This global increase in heat comes with increases in both number and duration of heat waves 3 . A recent study described the "temperature of equivalence" concept, which quantified the heterogeneity of surface temperature by geographical regions and demonstrated that low-income countries will bear a greater burden of severe heat events compared to high-income countries, even if target temperatures of less than 1.5°C are met 4,5 .
Pregnancy is a vulnerable time. Hyperthermia in the first trimester is teratogenic 6-8 and there is epidemiological evidence of increased preterm births, low birth weight (LBW) and stillbirths following maternal exposure to heat stress 9-13 , though data from Africa are sparse and contradictory [14] [15] [16] .
In temperate regions, a case-crossover study from California found an 8.6% increase in prematurity with every 5.6°C increase in ambient temperature exposure 17 . An intra-population analysis quantified the effect of heat on birth weight and found that heat explained 9.6% of the difference in birth weight between populations 18, 19 .
Heat stress (a combination of ambient temperature, humidity, solar radiation and wind speed) and the consequent heat strain (the physiological response to heat stress) have not been studied in pregnant women in the field. Heat strain presents as a spectrum from perceived discomfort to death 20 . There is almost no field-based physiology studies concerning the impact of heat stress on maternal physiology or the impact that it has on the developing fetus.
Temperature regulation
Healthy human bodies maintain a core temperature of around 37°C 21 . On a cellular level, this ensures an ideal environment for processes necessary for life, for example enzymes to work optimally and proteins to fold in the required configuration 22 . Heat balance is maintained when heat is lost at a similar rate to which it is produced or absorbed, as visualized in Figure 1 23 .
Heat loss can be altered by two mechanisms, autonomic thermoregulation where physiological processes take place without conscious effort, or behavioural thermoregulation, where conscious action is used to reduce body temperature. In certain situations the heat burden cannot be entirely avoided, for example agricultural workers and therefore in these situations the physiological mechanisms act to try and ensure heat balance is maintained. Thermal homeostasis is controlled by the preoptic anterior hypothalamus which receives afferent signals from thermal sensors in the skin and visceral core 24 . The efferent signals stimulate cutaneous vasodilation and sweating. These increase conductive, convective, radiative and evaporative heat loss, see Figure 2 .
In contrast to behavioural thermoregulation, which has a nearinfinite capacity to regulate body temperature, physiological responses to environmental heat stress have a finite capacity 25 . Heat acclimation (physiological adaptations due to repeated laboratory based heat training) and acclimatization (physiological adaptations due to repeated exposure to heat in the natural environment) improves a body's response to heat stress; however, at a certain point even these mechanisms will be overwhelmed and core body temperature will rise 26, 27 .
When the internal heat production increases due to increased metabolic demand and/or mechanical work, there is a delay in the body's response to the additional heat stress. On average it takes 45 minutes for a body to reach equilibrium, and prior to this there is heat storage in the body 27 . This is also followed by a post-exercise attenuation of heat dissipation, such that it may take 2 hours for a body to return to thermal equilibrium after exercise 28 . The impact of this on maternal and fetal physiology and health is unknown.
Pathophysiology of heat strain
When a body's capabilities to alleviate heat stress by thermoregulatory mechanisms are overwhelmed then heat strain develops, see Figure 3 .
When cutaneous vasodilation is stimulated, blood supply to the skin increases from around 1% of cardiac output to as high as 70% (6-8 L/min) 24,29 . This necessitates a large reduction in blood flow to internal organs, in particular the splanchnic and renal arteries, as well as a reduced venous return. If the heat stress continues, then hypovolaemia due to water and salt loss in sweat exacerbates the reduction in cardiac output and the consequent reduction in blood supply to internal organs. If this continues, there is a risk of acute kidney injury, and splanchnic and cerebral blood flow insufficiency. Interruption of the splanchnic blood flow has been shown to result in ischemia of the gastrointestinal membrane, which potentially results in translocation of gut bacteria and endotoxins 30 . If the heat stimulus is removed at this point, there is still the risk of developing systemic inflammatory response syndrome (SIRS), acute respiratory distress syndrome (ARDS), disseminated intravascular coagulopathy (DIC), multi-organ failure and death due to the stimulation of the pro-inflammatory cascade 31 .
Specific considerations in pregnancy
During pregnancy, maternal physiological changes are dramatic. Plasma volume increases by almost 50% in the third trimester, red blood cells increase by a lesser extent, giving a dilutional anaemia, and cardiac output also increases by around 50% 32,33 . The placental blood flow in the third trimester is 600-700 mL/min and is regulated by local vasoactive mechanisms rather than central neuronal command 34 .
In terms of thermal regulation, thermal capacity increases, core temperature decreases, heat production increases and surface-area-to-volume ratio decreases over the course of pregnancy 35 . Although some of these act to protect the pregnant woman, the overall impact of these mechanisms is a reduction in the ability to dissipate heat and an increased risk of heat strain in pregnancy. The fetal heat balance is dependent on fetal heat generation (metabolic rate), maternal temperature and uterine blood flow; however, the fetus itself has no ability to actively loose heat 8 . Heat loss occurs mainly through the umbilical artery, although some heat is lost to the amniotic fluid. The fetus is usually 0.4-0.6°C hotter than maternal core temperature, but in situations where maternal core temperature rises, this will result in heat transfer to the fetus 36,37 . The impact of heat on fetal development has been a difficult area to study. Women with pyrexia, usually from an infection, experience several other factors that affect the fetus, namely microbial factors, immune responses and maternal physiological response. Owing to the difficulty in isolating the effect of heat strain in human pregnancy little is known about the changes in placental blood flow, release of heat shock proteins and other chemical responses to heat strain and what these mean for fetal wellbeing. What is known is largely taken from the animal literature and heat stress has been shown to reduce birth weight in a variety of mammals. In particular, a large body of work has examined heat stress in ewes, where placental weight and size was diminished, blood flow to the uterine artery reduced and intrauterine growth retardation (IUGR), similar to stunting, was seen in animals in a chronic heat stress environment [38] [39] [40] [41] . The impact of heat stress varied with trimester, with increased rates of first trimester miscarriage and congenital abnormalities. Heat stress in the second and third trimesters resulted in IUGR and increased the incidence of stillbirth 42 . These studies give an insight into what may be occurring in humans; however, in many cases, it is difficult to directly transfer to the human condition due to large differences in the volume to surface area ratio, and in the relative mass of the products of conception. Consequently, the pregnant ewe has often be considered to be the optimal animal model but still has important differences (the rumen and fleece for instance) and therefore conclusions must be viewed with caution. Figure 4 gives an overview of the hypothetical impact of heat stress by trimester.
Climate change, occupational health and pregnancy
The knowledge gap relating to pregnancy in humans and exposure to heat stress is of current and growing concern as present conditions can be extreme for pregnant women and climate change predictions put the global temperature at levels not experienced in the last 200,000 years (i.e. the timespan modern humans have inhabited the earth). The burden of that heat stress will be mostly felt in low income countries with the least opportunity for adaptation 5 . It will also occur in areas where women make up almost 50% of the agricultural work force and work throughout pregnancy 43,44 .
Aims and objectives
We aim to assess whether heat strain in pregnant farmers in The Gambia acutely alter fetal wellbeing. The aims of this study are to:
1. Determine the heat stress exposure of pregnant farmers.
2. Determine the prevalence of heat strain by trimester and heat stress exposure in pregnant farmers. 
Methods

Study design
This is a prospective observational cohort study of pregnant women who perform outdoor agricultural work during pregnancy, which has been recruiting since August 2019.
Setting
This study will be conducted at Keneba field station, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine (MRCG @ LSHTM).
MRC Keneba is a rural field station based 2.5 hours inland from the coast, in Kiang West region where mostly subsistence agriculture is practiced. The climate in this area has two distinct seasons, the wet and dry season, which run from July to October and November to July, respectively. Farming of rice and groundnuts occur during the wet season and relies mostly on rainfall. In the dry season there are large "gardens", which are used to grow a variety of vegetables. These tend to be watered by hand.
Farming is a gender specific activity, with men growing the cash crops and women mainly growing food for household consumption or selling at the local markets. All agricultural work practiced by women in the region is done manually -planting, transplanting, weeding, harvesting, clearing, tilling and watering. Previous work in The Gambia has assessed the energy expenditure of pregnant women during different agricultural activities and also assessed the amount of time spent on these activities. These studies show that women will work between 50% to 83% of a 9-hour day on agricultural work, depending on the season, even when pregnant 45-48 . The mean monthly temperatures in 2017 varied from 25.4-30.3°C and maximum monthly temperatures from 31.5-39.5°C. The maximum monthly Wet Bulb Globe Temperature (WBGT) varied from 24.7-29.3°C. This gives the exposure during the hottest times of the day. This exposure is at a level that international guidelines would identify as at risk of heat illness. The annual average temperature rise since 1980 is just below 1°C (REF). Most villages do not have electricity and therefore no access to air conditioning or electric fans. Water is mostly supplied through public bore holes, although some homes do have tapped water.
Participants and recruitment
Community sensitization and discussion will occur in each village prior to any visits. Once agreement and consent from the village elders has been obtained, we will recruit 125 participants.
Pregnant women will be approached and informed about the study in their preferred language. Inclusion and exclusion criteria are set out below. 
History of cardiac disease
Sample size
Previous studies on physiological changes in pregnant women working in heat have not been completed. Based on published literature, we expect around 35% of agricultural workers to experience heat strain and assume this incidence risk remains at least as high in pregnancy 49,50 . Assuming an unexposed incidence risk of fetal distress to be 5% with an alpha of 0.05, we will need to recruit 99 participants to be powered to detect an exposed incidence risk of 30% with fetal distress. Taking into account drop-out rates due to fetal loss, we will recruit 125 participants.
Study procedures
Pregnant women, of any gestation, identified by the demographic surveillance system (DSS), antenatal clinics or village assistants will be approached and consented if eligible. They will attend the Keneba antenatal clinic where socio-economic, demographic, medical and obstetric details will be collected These will include any past medical history, past obstetric history including previous miscarriages, stillbirths, premature births or low birth weight infants. A baseline ultrasound will be performed by a trained member of staff. Gestational age will be determined based on an early ultrasound scan (under 28 weeks gestation) using biparietal diameter. If an early ultrasound scan has not been performed then biparietal diameter will still be used but with the expectation of reduced accuracy in the estimation of gestation. In women between 28-34 weeks we will perform an UmbiFlow™ scan. The UmbiFlow™ device was designed in South Africa for use in low-resource settings to identify women at risk of poor birth outcomes due to placental pathology. It measures the resistance index (RI) in the umbilical artery and plots this on a normogram based on gestational age (see Figure 5 for an example). This device is designed for use by unskilled practitioners and requires minimal training. It has been validated for gestational ages 28-34 weeks 51,52 .
Within the next 2 weeks, on the day they are working outside, they will attend Keneba field station where they will have baseline anthropometry, physiology readings and blood and urine collection. They will be fitted with an Equivital™ LifeMonitor device. This is a portable, multi-parameter telemetry device that sits within a Lycra chest belt with inbuilt fabric sensors 53 . Once wearing the LifeMonitor device they will complete a 6-minute walk test to determine cardiovascular reserve and calibrate the device 54 .
During the working day (duration recorded) we will record their tympanic temperature and the ambient conditions every hour. At middle and end of day we will assess fetal heart rate ± umbilical artery flow. Maternal measurements will include a four-point skin temperature using an infrared, non-contact thermometer. Measurements are taken from four-left-hand sided points from 20 cm away; chest, mid-tricep, mid-thigh and mid-calf 55 . A Perfect ® Prime thermal imaging camera IR10019 with a resolution of 320 x 240 and pixels of 76,800 will be used to take two pictures per time point; from the waist up (with head-dress removed), and from the waist down (with legs revealed). Heart rate and blood pressure will be measured with an automatic OMRON M3 Intellisense device. Standardised ratings for thermal sensation and comfort will be recorded. At the end of the participant's normal working day we will collect end line blood and urine and take a final measurement of weight and bioimpedence. Participants will be followed every 2 months during the course of their pregnancy. Figure 6 and Figure 7 give an overview of study processes and timing.
After delivery, data will be collected on birth outcome, birth weight, gestational age, infant sex and maternal and newborn status. Recruitment will be over a 12-month period to ensure different seasonal exposure to work and heat. By recruiting over the course of a year and repeating measures every two months we will capture different trimesters for the same women. This will give us an estimate of the physiological changes that occur at different heat exposures and by different trimesters and identify if these alterations lead to altered fetal wellbeing.
Primary outcome measures
The primary outcome is a measurement of fetal distress. We define compromised fetal wellbeing as either: (i) a baseline fetal heart rate above 160 bpm or below 115 bpm; and/or (ii) if the fetus is 28-34 weeks gestation, then UmbiFlow™ above the 75th percentile of established resistance index graphs, or absent end diastolic flow, in keeping with the findings from South Africa and the developers of UmbiFlow™ 51,52 .
Laboratory sample collection and processing Study staff will collect a venous blood and urine sample for each participant for use in study laboratory procedures. All samples aim to identify maternal heat strain or fetal wellbeing. Table 1 gives the laboratory sampling and justification. Whole blood samples from each participant will be used to prepare six dried blood spots of 10 µl each on filter paper and stored for biomarker testing. Serum samples will be separated and stored at -80°C for future analysis.
Statistical analyses
Statistical analysis will be performed using R. Appropriate descriptive analysis will be used to present maternal characteristics and environmental heat stress exposures. Data will be assessed for normality and skewed data will be appropriately transformed.
Derived values
Metabolic rate and energy expenditure will be determined from the raw accelerometer and heart rate data using complex non-linear modelling. The 6-minute calibration test will allow development of individual and trimester specific estimates of metabolic rate. These will be cross-checked against historic data on energy expenditure of pregnant women in West Kiang per activity type.
Heat strain will be determined by either the physiological strain index (PSI) or the Center for Disease Control (CDC) recommended signs and symptoms score.
The PSI model is based on changes in heart rate and core body temperature and therefore gives an indication of the combined thermal and cardiovascular load: The CDC method is based on a series of symptoms related to heat illness, which vary from heat rash to heat stroke 58 . We will include those related to heat stroke, heat exhaustion and heat cramps or a core temperature above 38°C, but will not include symptoms of heat rash or sunburn as these are not related to the physiological changes we are interested in. There are several heat stress indices we will calculate based on the direct field measurement we will take. These will include the WBGT, the Universal Thermal Climate Index, the apparent temperature and the heat index.
Primary outcome analysis
A mixed-effect linear model will be run, using lme4 package in R to allow fixed and random effects to be incorporated appropriately. Fetal compromise(ij) = presence or absence of fetal distress as defined above for individual i at gestational month j (1…9).
Secondary outcome analysis
Different commonly used heat stress indices as described above will be validated against heat strain data for clinical correlation. Changes in fetal heart rate from baseline, stratified by trimester will be explored. Heart rates > 170 and > 180 will also be used as cut offs for fetal distress, although the numbers may be small. Changes in biomarkers of heat strain or feto-placental function will be analysed by ANOVA stratified by trimester and heat stress exposure.
Safety and ethical considerations
This study has been approved by the Gambia government/ MRC Joint ethics committee (ref: 16405) and the London School of Hygiene and Tropical Medicine Ethics Advisory Board.
Written informed consent and information sheets will be provided to all participants. A trained study staff member will conduct individual screening interviews and informed consent procedures in the preferred language of the participant. If the participant is unable to write, her fingerprint will be used as substitute for a signature, and an impartial adult witness to the entire consent procedure will provide their signature.
Potential participants will be able to ask questions and discuss the study with study staff at any time during and after study activities. Participants are free to withdraw consent at any time during the course of the study and this will not impact on future care provision.
Risks associated with participating in this study are minimal. Participants will be screened at the start of the day and should they demonstrate any signs or symptoms of illness or concern they will be advised to seek the attention of the Keneba health clinic and participation in the study will be delayed until they are well. Should a participant be hypertensive but not pre-eclamptic then may still enter the study, but we will refer them to antenatal services for treatment of their hypertension. Should a participant develop pre-eclampsia after recruitment, diagnosed at antenatal clinic or on subsequent visits, they will be referred to Keneba antenatal services and not included in the daily assessment of maternal heat strain and fetal wellbeing. However, if they are willing to remain in the study, pregnancy outcome data will still be collected.
Participants will have additional venous blood samples taken using aseptic technique with universal precautions to minimize the risk of infection, personal discomfort, transient bleeding and bruising that may result. An ultrasound scan is part of routine antenatal care and an additional scan adds no harm to maternal or fetal health. The risks of wearing the portable recording devices include chaffing of the skin and discomfort, which we will minimize by ensuring a good fit at the beginning of the day and checking for any skin irritation at the end of the day.
During the 6-minute walk test the participant can stop at any point during the course of the exercise and standardised feedback was collected. Additionally, this test will be performed at Keneba field station, close to the clinic area and if any untoward symptoms are experienced, they will assess and treat the participant as required.
During the course of the day, if a significant heat load is experienced and the maternal core temperature increases beyond 38.5 o C (see below) the guidelines on treatment of heat strain will be followed with some additional considerations. In non-pregnant individuals, heat strain is determined to be a lifethreatening emergency requiring immediate treatment when core temperature reaches 40.5°C 31 . In pregnancy, heat is known to be teratogenic in the embryonic period, and throughout pregnancy compensatory mechanisms may be compromised. Hence we do not think it is ethical to allow the temperature to reach such a high level. Therefore, should maternal core temperature reach 38.5°C, this would result in an immediate review and treatment of heat strain would be commenced. This would include an overall clinical assessment of the women and fetus, immediate measures to treat the women and if these did not result in improvement within 30 minutes, consideration of transfer to the health facility.
If during the intermittent measurements of fetal wellbeing, there are any concerns with fetal heart rate (either >160 or <115) 66 , or regarding the Doppler results, then the participant will be assessed, encouraged to rest in the left lateral position, consume water, and have observations of fetal movement and maternal blood pressure taken. If after 30 minutes, the baseline heart rate has not returned to the normal range, the Doppler remains abnormal, or there are any clinical concerns, the women will be offered transport to the health clinic for further review and treatment. Any such events will be recorded as an incident case of fetal distress as per the primary outcome of this study.
Limitations
This is a field-based study in rural West Africa and therefore there are several limitations when comparing it to a laboratory based heat chamber study. We aim to characterize the physiological response of pregnant women to heat stress. Due to ethical considerations, this is an observational study only. Therefore if the women are not exposed to extreme heat in their usual work, we will not be able to measure this effect. However, from previous work in this setting, women were working in the heat during pregnancy and therefore we are confident that the exposure will occur.
Since we are recruiting women who work in the gardens or farms during pregnancy, we are aware that our sample may be biased towards those in the lowest socio-economic group, which may affect the generalisability of the result. However, we consider this group to be of particular importance as they are likely to have little options for modification of behaviour or development of adaptation strategies. We will use Demographic Health Surveillance Data to compare our sample with the wider pregnant community over the time period of our study to determine the representation in the sample and any significant sources of bias.
Our physiology measurements do not include continuous core temperature monitoring as would be the gold standard, due to practical constraints of field work. We therefore use tympanic temperature as a measure of core temperature, recognising the deficiencies in this measurement. Due to well documented measurement errors in this method, we are likely to underestimate the true temperature rise. Additionally the Equivital device measurements, heart rate, respiratory rate, skin temperature and tri-axis accelerometer will all have measurement errors. We will attempt to minimise these by removing impossible values, cleaning the signal and using the inbuilt algorithms for percentage confidence in the results.
Due to the practicalities of accessing remote rice fields, and transporting all necessary equipment we will be unable to accurately assess water intake. Our assessment of hydration therefore is at the physiological level, but this is a limitation in the methodology especially considering that hydration is an important aspect of thermoregulation.
Confidentiality and access to data All participants will be allocated a unique identifying number (UIN) at recruitment. Data generated by the wearable sensors will be downloaded from the devices at the end of the day, linked to the UIN and then wiped. During the study day, data will be collected on tablets using the REDCap application. On return to Keneba field station the tablets are synced, allowing transfer of encrypted data to the designated server.
All data will be backed up regularly by the IT department in accordance with MRC SOP-INT-001. The database is centrally stored, data is secure and encrypted and held by MRC/LSHTM. No personal identifiable information will be available in any shared or published document. Primary data outputs will be in XML format. All study documents will be filed and stored for at least 10 years.
Dissemination
The results of the study will be analysed and prepared for publication in open-access peer-reviewed international journals, staggered over time. At the end of the project a community event will be held to disseminate results to all those communities that participated in the study. We will comply with international standards and guidelines regarding open access of research data.
Conclusion
This study will be the first to characterize the heat stress, heat strain and fetal status in pregnant farmers and with these results we hope to describe the problem, measure the incidence of significant threats to fetal well-being, and to highlight the need 1.
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individuals who will perform ultrasounds?
Related to the above, I am concerned that LMP and biparietal diameter (BPD) will be used interchangeably. In how many women is LMP expected to be used? Will LMP also be recorded for those with BPD measurements to see how they compare?
How will the gestation at ultrasound scan be considered? My understanding is that at 12-26 weeks, it is accurate +/-10-11 days, and after 27 weeks, it is accurate +/-2-3 weeks. It would be good to give some detail on the limitations of using a single BPD measurement. If possible, paired BPD measurements at two timepoints would improve the accuracy of estimating gestational age.
Will hypertensive women be included? It is not mentioned in the exclusion criteria, but presumably anyone who is identified as hypertensive at time of consent will be excluded?
Will participants be blinded to their measurements, or will it be fed back to them each day? I wonder how they many adapt their behaviour in subsequent days if they are aware of their previous measurements (of course exempting when there are concerns of maternal/fetal wellbeing, which will rightly result in intervention).
Finally, there is not much detail provided on what clinical parameters will be recorded that may be important to consider in any analysis. E.g. maternal age, ethnicity, BMI, parity, gravidity, previous pregnancy pathologies (e.g. miscarriage, stillbirth, pre-eclampsia, preterm birth, gestational diabetes).
Is the rationale for, and objectives of, the study clearly described? Yes
Is the study design appropriate for the research question? Yes
Are sufficient details of the methods provided to allow replication by others? Partly
Are the datasets clearly presented in a useable and accessible format?
Not applicable
No competing interests were disclosed.
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Reviewer Expertise: Pregnancy, maternal-fetal health, placental biology, immunology, maternal vaccination, extracellular vesicles I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Thank you for your time and effort in providing the feedback on the paper. We are very grateful for Thank you for your time and effort in providing the feedback on the paper. We are very grateful for the scientific review and hope that the changes we have made in response to the suggestions make the article stronger scientifically.
1. More information is needed on the exact gestation that will be studied. This should be clearly stated in the inclusion/exclusion criteria. It is not stated when women will be approached and consented, and hence what gestation the 2-week study period will cover. It is only mentioned that the UmbiFlow will be performed on women between 28-34 weeks. Is this the target gestational period that will be studied?
We decided to include any gestation. Since we repeat our field measurements every two months, we hope to get at least 2 visits per participant. Due to the variation in climate exposures we did not want to limit the gestation we would explore at the start of the project since those environmental conditions (hot and humid) only last 3 months. If we limited the recruitment to early gestation then we would not have late pregnancies exposed to those conditions. This has been made clearer in the manuscript.
2. Related to the above, including a wide range of gestations could impact on the required sample sizes, as gestation could play an impact on either physical exertion (i.e. the mother resting more in later gestation), or on the sensitivity of the fetus to stress. I would like to know a bit more about the range of gestation that will be studied, and how gestational age will be considered in the analysis (i.e. will stratification be performed).
Gestation will be included in the analysis. We will begin by exploring the results stratified by trimester, but will consider using a fixed effect of gestational weeks or months in the full model. Stratification by trimester will be used for analysis of heat strain, biochemistry changes and changes in osmolality. This has been made clearer in the manuscript 3. Will liquid intake be monitored? This could have an impact on maternal wellbeing, and also impact on urine and blood analyses. Perhaps water could be provided in reusable bottles, and the amount left over at the end of the day recorded. This is a very important point. Unfortunately our study has taken us to remote areas where our 4WD is unable to reach. We have then had to carry all our equipment out into the field. Due to these constraints we have been unable to do this. I will add this as a limitation 4. Will blood samples at the beginning of the day be fasted samples, or after eating? Same for the end of the day sample -will the time since their last meal be recorded?
Blood samples will not be taken fasted 5. Normal fetal heart rate varies with gestation. It would be good to consider this in the study. It would also be good to include HR >170 and >180 in the secondary analysis.
This will be added to our secondary analysis. Additionally we will also look at the change in fetal heart rate from at rest in a cool room to when working in the field and so use individual resting rates as our baseline. 6. Accurate estimation of gestation could be quite important in this study. It is not clear how often early ultrasounds will be performed. Has capability been built in this area? Are there designated individuals who will perform ultrasounds? Ultrasound scans will be performed by 1 midwife or 1 doctor who have undergone training in fetal scanning and dating measurements. This has been clarified in the manuscript 7. Related to the above, I am concerned that LMP and biparietal diameter (BPD) will be used interchangeably. In how many women is LMP expected to be used? Will LMP also be recorded for those with BPD measurements to see how they compare?
This has been altered as you suggest. LMP is very unreliable in this setting. Therefore we will use BPD only for dating.
8. How will the gestation at ultrasound scan be considered? My understanding is that at 12-26 weeks, it is accurate +/-10-11 days, and after 27 weeks, it is accurate +/-2-3 weeks. It would be good to give some detail on the limitations of using a single BPD measurement. If possible, paired BPD measurements at two timepoints would improve the accuracy of estimating gestational age.
Gestational dating will be based on ultrasound. Most participants will have had an ultrasound prior to 28 weeks (giving an accuracy to +/-14 days). If the participant has not been identified early enough then this will be recorded and gestational dating will be based on BPD but with the caveat of reduced accuracy. This has been altered in the protocol to make clearer 9. Will hypertensive women be included? It is not mentioned in the exclusion criteria, but presumably anyone who is identified as hypertensive at time of consent will be excluded?
If participants are hypertensive but not pre-eclamptic they will be included. If they develop pre-eclampsia then they will be excluded. This has been made clearer in the manuscript 10. Will participants be blinded to their measurements, or will it be fed back to them each day? I wonder how they many adapt their behaviour in subsequent days if they are aware of their previous measurements (of course exempting when there are concerns of maternal/fetal wellbeing, which will rightly result in intervention).
Participants will be made aware of concerns to fetal wellbeing or raises in core temperature above 38.0 degrees. Otherwise they will not have measurements fed back to them 11. Finally, there is not much detail provided on what clinical parameters will be recorded that may be important to consider in any analysis. E.g. maternal age, ethnicity, BMI, parity, gravidity, previous pregnancy pathologies (e.g. miscarriage, stillbirth, pre-eclampsia, preterm birth, gestational diabetes).
All these parameters will be collected. This has been added to the manuscript to make it clear.
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asess. I really dount the core temp will rise, certainly not by the hour! She may have heat stress and discomfort but for that to raise her temperature is unlikely I imagine.
The sample size refers to the 30% increases incidence in the primary outcome?
Is the rationale for, and objectives of, the study clearly described? Yes
Is the study design appropriate for the research question? Yes
Are sufficient details of the methods provided to allow replication by others? Partly
Not applicable
heat stress on maternal physiology...; there is a lot written about thermoregulation in pregnancy, and it is fascinating. I completely agree, there is a lot of data on thermoregulation in pregnancy, but field-based physiology studies in heat stressed human pregnancies are lacking. I have rephrased the sentence to more accurately reflect this.
4. The claim about hyperthermia being a teratogen in humans is perhaps over-stated. As I understand there is still a controversy about this in terms of saunas etc.
Hyperthermia is a teratogen in the first trimester, as shown from fever studies and studies with documented prolonged rises in core temperature. I have clarified that it is a teratogen in the first trimester in the manuscript. 5. I wonder if it might be better to target the physiological measurements to days above a certain temperature threshold, based on forecasting. That is the key question I think, It depends what your question is: impact of total heat burden during pregnancy, or impact of 'extreme heat'. If it is the later then measures on days with Tmax >90th percentile might make more sense.
This would give us a detailed idea of extreme heat. However without the ability to compare to physiological changes at cooler times it would be difficult to differentiate the heat from the exercise effects. This was the rational to recruit throughout the year.
6. The ability of women to thermoregulate in pregnancy is remarkable I think, their relative 'hypothermia' and shifting of blood away from the fetus means that you may not detect any major impact, a major missed opportunity
The ability to thermoregulate is impressive, however the conditions here in The Gambia are extreme in terms of what we as humans can adapt to. In particular if occupational guidelines were followed the max WBGT is often above the level at which outdoor work is advised. Therefore even with a starting relative hypothermia we expect to see some changes. Additionally, the shifting of the blood away from the fetus is a very important physiological change to document as a starting point to understand the impact of heat in pregnancy. I have added detail on the max WBGT we expect the women to be exposed to and how this puts them at risk of heat illness according to the ACGIH 7. I wonder if you need a limitations section, the one limitation under participants did not make sense to me. How much will behaviours change with the presence of a field worker? The hourly tympanic membrane measure seems excessive intrusion that may alter the behaviour you are trying to asess. I really dount the core temp will rise, certainly not by the hour! She may have heat stress and discomfort but for that to raise her temperature is unlikely I imagine.
A limitations section has been added. The taking of hourly tympanic membrane measurements was a compromise as we were unable to measure continuous core temperature as would have been the gold standard in heat strain studies. Rectal temperature was impossible and core telemetry pills have yet to be proved safe in pregnancy. In heat chamber studies, volunteers will put their core temperature up within 20 mins of exercise in a hot/humid environment and this will return to baseline relatively quickly which is the rational for the hourly measurements.
8. The sample size refers to the 30% increases incidence in the primary outcome? 8. The sample size refers to the 30% increases incidence in the primary outcome?
Yes, this is for the primary outcome I have clarified this in the manuscript none Competing Interests:
